ETENDERS

Contract notice

Information

Published

Date of dispatch of this notice: 04/09/2020

Expire date: 09/10/2020

External Reference: 2020-205573

TED Reference: 2020/S 175-423018

Contract notice

[NoticeContract]

[Directive201424]

[Section1]: [Ca]

I.1)

[NameAddressContact]

Department of Agriculture, Food and the Marine
N/A
Agriculture House
Dublin 2
Kildare Street
IE
[Contactpoint]: Peter Collins
[AddressEmail]: PeterM.Collins@agriculture.gov.ie
[Internets]:
[UrlGeneral]: http://www.agriculture.gov.ie
[UrlBuyerprofile]: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/307

I.3)

[InfoTendering]

[AddressObtainDocs]:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=173383&B=ETENDERS_SIMPLE
[AddressFurtherinfo]
[AsContactsAbove]:  
[AddressSendTendersRequest]
[AddressSendTenders]:  http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=173383&B=ETENDERS_SIMPLE
[AddressSendTendersRequest]
[AddressToAbove]
I.4)

[CaType]

[MaintypeMinistry]
I.5)

[Mainactivity]

[MainactivGeneral]

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

Sample Analysis of Food of Animal Origin for Ireland’s National Residue Control Programme
[Fileref]:  RFT 175705
II.1.2)

[CpvMain]

71900000  - 
II.1.3)

[TypeContract]

[Services]
II.1.4)

[DescrShort]

The purpose of this Request for Tender (RFT) is to set up Service Contracts for the provision of external laboratory analysis services (screening and confirmatory analysis). The RFT provides for a number of Lots. Tenderers may tender for one or more Lots.
The Contracting Authority requires laboratories to carry out (a) screening and/or (b) confirmatory analysis on a range of Samples (animal tissue, plasma, serum, urine, honey, milk, water and eggs) collected under Ireland’s National Residue Control Programme (NRCP).
II.1.5)

[ValueMagnitudeEstimatedTotal]

[ValueExclVat]: 350000.00  EUR
II.1.6)

[LotsInfo]

[DivisionLots]: [Yes]
[LotsSubmittedFor]  [LotsAll]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: A4 Resorcylic acid lactones including Zeranol – Substances listed in Appendix 1A – Urine
[LotNumber]:  1
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: A3 Steroids – 17-beta Oestradiol / 17-beta Testosterone / Progesterone
[LotNumber]:  2
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month extension
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: A3 Steroids – 17-alpha Trenbolone – Urine Matrix
[LotNumber]:  3
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month extension
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: A3 Steroids – 17-alpha-Nortestosterone – Urine Matrix
[LotNumber]:  4
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month extension
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: A3 Steroids – Boldenone – Urine Matrix
[LotNumber]:  5
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month extension
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: A3 Steroids – Ethynyl Oestradiol – Urine Matrix
[LotNumber]:  6
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: A3 Steroids – 17-beta Oestradiol & Ethynyl Oestradiol – Milk Matrix
[LotNumber]:  7
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month extension
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances – Colistin – Muscle Matrix
[LotNumber]:  8
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances – Clavulanic Acid – Muscle Matrix
[LotNumber]:  9
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances – Aminoglycosides (to include Paromoymycin) – Muscle Matrix
[LotNumber]:  10
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month extension
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances – Colistin – Milk Matrix
[LotNumber]:  11
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances – Bacitracin – Milk Matrix
[LotNumber]:  12
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month extension
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances – Novobiocin – Milk Matrix
[LotNumber]:  13
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances – Clavulanic Acid – Milk Matrix
[LotNumber]:  14
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances & Dapsone (A6) - Substances listed in App. 1A – Eggs Matrix
[LotNumber]:  15
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Screening: B1 Antibacterial Substances – Colistin – Eggs Matrix
[LotNumber]:  16
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1A of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: A2 Thyrostats – Substances listed in Appendix 1B – Water Matrix
[LotNumber]:  17
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: A3 Steroids – 17-beta Oestradiol & Ethynyl Oestradiol – Milk Matrix
[LotNumber]:  18
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Clavulanic Acid – Muscle Matrix
[LotNumber]:  19
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Colistin – Muscle Matrix
[LotNumber]:  20
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Aminoglycosides (to include Paromoymycin)– Kidney Matrix
[LotNumber]:  21
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances - Aminoglycosides (to include Paromoymycin)– Muscle Matrix
[LotNumber]:  22
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Cefalosporins – Muscle Matrix
[LotNumber]:  23
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Macrolides – Muscle Matrix
[LotNumber]:  24
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Quinolones – Muscle Matrix
[LotNumber]:  25
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory:B1 Antibacterial Substances – Plueuromutilins – Substances listed in App.1B – Muscle
[LotNumber]:  26
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Novobiocin – Milk Matrix
[LotNumber]:  27
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Clavulanic Acid – Milk Matrix
[LotNumber]:  28
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Colistin – Milk Matrix
[LotNumber]:  29
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Bacitracin – Milk Matrix
[LotNumber]:  30
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Substances listed in Appendix 1B – Milk Matrix
[LotNumber]:  31
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Substances listed in Appendix 1B – Eggs Matrix
[LotNumber]:  32
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances – Colistin – Eggs Matrix
[LotNumber]:  33
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2)

[Description]

II.2.1)

[TitleContract]

Confirmatory: B1 Antibacterial Substances & Dapsone(A6) - Substances listed in App.1B – Honey Matrix
[LotNumber]:  34
II.2.2)

[CpvAdditional]

85111820  - 
II.2.4)

[DescrProcurement]

See Appendix 1B of published tender documents
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 12
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
One possible 12-month renewal
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]

[Section3]: [InfoLegal]

III.1)

[ConditionsParticip]

III.1.2)

[EconomicFinancialStanding]

[CriteriaSelectionDocs]
III.1.3)

[TechnicalCapacity]

[CriteriaSelectionDocs]
III.2)

[ConditionsContract]

III.2.3)

[StaffResponsible]

[StaffResponsibleIndicate]

[Section4]: [Procedure]

IV.1)

[Description]

IV.1.1)

[TypeProcedure]

[ProctypeOpen]
IV.1.8)

[GpaInfo]

[GpaCovered] : [Yes]
IV.2)

[InfoAdmin]

IV.2.2)

[LimitReceiptTendersReqPart]

[Date]:  09/10/2020
[Time]:  17:00
IV.2.4)

[LanguagesAllowed]

[Language_EN]
IV.2.6)

[MinTimeMaintain]

[DurationMonths] : 6  ([FromStatedDate])
IV.2.7)

[OpeningConditions]

[Date]:  09/10/2020
[Time]:  17:00

[Section6]: [InfoComplement]

VI.1)

[RecurrenceInfo]

[RecurrentProcurement]:  [No]
VI.2)

[InfoEworkflow]

[EinvoicingUsed]
[EpaymentUsed]
VI.4)

[AppealsProcedure]

VI.4.1)

[AppealsBody]

High Court of Ireland
Dublin
IE